Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05160779Not ApplicableUnknown

Impact of Genetic Polymorphisms of Vasoactive Peptides on the Prognosis of Patients With COVID19

Role: lead

NCT04997746Unknown

Educational Guidelines Aimed at Pre-frail Elderly: Intervention Proposal

Role: lead

NCT04958980Not ApplicableUnknown

Multiprofessional Approach in Diabetes Mellitus

Role: lead

All 3 trials loaded